Navigating evolving regulatory CMC guidance in the AAV gene therapy field

 Elisa Manzotti, CEO of BioInsights, speaks to (pictured left to right) Michael Brewer, Director, Global Principal Consultant, Regulatory, Bioproduction Group, Thermo Fisher Scientific, Alexis Cockroft, Director & Regulatory Consultant, Lex Regulatory Ltd, Christina Fuentes, Senior Consultant, Dark Horse Consulting Group, Christine Le Bec, Head of CMC Gene Therapy, Sensorion Pharma & Yan Zhi, Director and Cell and Gene Therapy Product Owner, Process Engineering, CSL Behring 

Please enter your email to access content Read now